199 related articles for article (PubMed ID: 36143968)
1. Algorithm of Femoropopliteal Endovascular Treatment.
Dubosq M; Raux M; Nasr B; Gouëffic Y
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143968
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
[No Abstract] [Full Text] [Related]
3. Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence.
Giannopoulos S; Armstrong EJ
Expert Rev Cardiovasc Ther; 2019 Oct; 17(10):729-740. PubMed ID: 31575289
[No Abstract] [Full Text] [Related]
4. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
6. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
[TBL] [Abstract][Full Text] [Related]
8. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
9. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
Mohapatra A; Saadeddin Z; Bertges DJ; Madigan MC; Al-Khoury GE; Makaroun MS; Eslami MH
J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761
[TBL] [Abstract][Full Text] [Related]
10. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.
Aru RG; Tyagi SC
Semin Vasc Surg; 2022 Jun; 35(2):180-189. PubMed ID: 35672108
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
Krishnan P; Farhan S; Schneider P; Kamran H; Iida O; Brodmann M; Micari A; Sachar R; Urasawa K; Scheinert D; Ando K; Tarricone A; Doros G; Tepe G; Yokoi H; Laird J; Zeller T
J Am Coll Cardiol; 2022 Sep; 80(13):1241-1250. PubMed ID: 36137674
[TBL] [Abstract][Full Text] [Related]
12. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
13. [Endovascular treatment of femoropopliteal arterial occlusive disease].
Kerzmann A; Boesmans E; Holemans C; Quaniers J; Alexandrescu V; Defraigne JO
Rev Med Liege; 2020 Nov; 75(11):717-723. PubMed ID: 33155445
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
15. Atheromatous occlusive lesions of the popliteal artery treated with stent grafts: predictive factors of midterm patency.
Peidro J; Boufi M; Loundou Dieudonné A; Hartung O; Dona B; Vernet F; Alimi Y
Ann Vasc Surg; 2015; 29(4):708-15. PubMed ID: 25595105
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive stent use during endovascular intervention to the femoropopliteal artery with drug coated balloons: Insights from the XLPAD registry.
Kokkinidis DG; Jeon-Slaughter H; Khalili H; Brilakis ES; Shammas NW; Banerjee S; Armstrong EJ
Vasc Med; 2018 Aug; 23(4):358-364. PubMed ID: 29923459
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
[TBL] [Abstract][Full Text] [Related]
18. Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.
Zeller T; Rastan A; Macharzina R; Beschorner U; Noory E
Curr Cardiol Rep; 2015 Sep; 17(9):624. PubMed ID: 26238739
[TBL] [Abstract][Full Text] [Related]
19. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery.
Katsanos K; Spiliopoulos S; Karunanithy N; Krokidis M; Sabharwal T; Taylor P
J Vasc Surg; 2014 Apr; 59(4):1123-1133.e8. PubMed ID: 24661896
[TBL] [Abstract][Full Text] [Related]
20. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
